Last reviewed · How we verify
NCT04358757
Immune and Physical Recovery Following Cesarean Delivery
trial testing Elective cesarean delivery in Cesarean Delivery in 60 participants. Completed in 23 December 2023.
23 September 2023
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 22 November 2019 |
| Primary completion | 23 September 2023 |
| Estimated completion | 23 December 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Elective cesarean delivery
Conditions studied
- Cesarean Delivery — all drugs for Cesarean Delivery →
Sponsor
Stanford University
Who can join
Adults 18 to 50, female only, with Cesarean Delivery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pregnancy results in an altered immune state compared to the nonpregnant population. A significant proportion of women undergoing cesarean delivery recover poorly. The first step to determining whether this is an immune driven / associated process is to characterise what effects this surgery has on maternal immune function. "Normal" changes will be evaluated in maternal immune function and activity precipitated by surgery and delivery of the neonate. Immune response to surgery will be compared to historical immune data from patients undergoing non-obstetric surgery (orthopaedic patients).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04358757
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Elective cesarean delivery
Trials testing the same drug.
- NCT03063853 — Removal of Surgical Staples After Cesarean Delivery. Randomized Control Trial. · NA · completed
Other recruiting trials for Cesarean Delivery
Currently open trials in the same condition.
- NCT07322419 — Hemodynamics During Cesarean Delivery Under Spinal Anesthesia With Norepinephrine Versus Ephedrine · Phase 4 · recruiting
- NCT07326644 — Effect of Gestational Weight Gain on Spinal Anesthesia in Elective Cesarean Delivery · recruiting
- NCT07197398 — Preoperative Data and the Spinal Spread of Local Anesthetic in Cesarean Section · recruiting
- NCT07082530 — A RCT of Labor Induction at 39 Weeks in Low - Risk Women in China · NA · recruiting
- NCT07006896 — Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin · NA · recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04358757 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 21 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04358757.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing